CardiologyQuarterly jab cut pancreatitis attacks in very high triglycerides
In two phase 3 trials of 757 adults, plozasiran lowered triglycerides by about 80% and cut acute pancreatitis rates, though the result rests on 18 attacks over a single year.
4 November 2026